Work

Abstract CT066: Therapeutic advances for high-risk and steroid-refractory aGvHD: Promising results from the phase 1b study of MSCTC-0010 Wharton's jelly mesenchymal stem cells (WJMSC)

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct066

Authors: William C. Wesson, Jianzheng Wu, Milind Phadnis, Scott Weir, Tyce Bruns, Haitham Abdelhakim, Rupal Soder, Ramesh Balusu, Sunil Abhyankar, Joseph P. McGuirk

Institution: University of Kansas Medical Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822250

Cites:

Cited by:

Related to: 10